Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5YP1

Crystal structure of dipeptidyl peptidase IV (DPP IV) from Pseudoxanthomonas mexicana WO24

5YP1 の概要
エントリーDOI10.2210/pdb5yp1/pdb
関連するPDBエントリー5YP2 5YP3 5YP4
分子名称Dipeptidyl aminopeptidase 4, GLYCEROL (3 entities in total)
機能のキーワードdap iv, clan sc s9, peptidase, dpp4, dpp8, dpp9, hydrolase
由来する生物種Pseudoxanthomonas mexicana
細胞内の位置Isoform 2: Cytoplasm . Isoform 1: Periplasm : Q6F3I7
タンパク質・核酸の鎖数4
化学式量合計329594.09
構造登録者
主引用文献Roppongi, S.,Suzuki, Y.,Tateoka, C.,Fujimoto, M.,Morisawa, S.,Iizuka, I.,Nakamura, A.,Honma, N.,Shida, Y.,Ogasawara, W.,Tanaka, N.,Sakamoto, Y.,Nonaka, T.
Crystal structures of a bacterial dipeptidyl peptidase IV reveal a novel substrate recognition mechanism distinct from that of mammalian orthologues.
Sci Rep, 8:2714-2714, 2018
Cited by
PubMed Abstract: Dipeptidyl peptidase IV (DPP IV, DPP4, or DAP IV) preferentially cleaves substrate peptides with Pro or Ala at the P1 position. The substrate recognition mechanism has been fully elucidated for mammalian DPP IV by crystal structure analyses but not for bacterial orthologues. Here, we report the crystal structures of a bacterial DPP IV (PmDAP IV) in its free form and in complexes with two kinds of dipeptides as well as with a non-peptidyl inhibitor at 1.90 to 2.47 Å resolution. Acyl-enzyme intermediates were observed for the dipeptide complexes of PmDAP IV, whereas tetrahedral intermediates were reported for the oligopeptide complexes of mammalian DPP IVs. This variation reflects the different structural environments of the active site Arg residues, which are involved in the recognition of a substrate carbonyl group, of mammalian and bacterial enzymes. A phylogenetic analysis revealed that PmDAP IV is a closer relative of dipeptidyl peptidases 8 and 9 (DPP8 and DPP9, DPP IV-family enzymes) than DPP IV. These results provide new insights into the substrate recognition mechanism of bacterial DAP IVs and may assist in the development of selective inhibitors for DAP IVs from pathogenic asaccharolytic bacteria, which utilise proteins or peptides as an energy source.
PubMed: 29426867
DOI: 10.1038/s41598-018-21056-y
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.47 Å)
構造検証レポート
Validation report summary of 5yp1
検証レポート(詳細版)ダウンロードをダウンロード

226707

件を2024-10-30に公開中

PDB statisticsPDBj update infoContact PDBjnumon